Last reviewed · How we verify
bortezomib, rifampicin
bortezomib, rifampicin is a Small molecule drug developed by Millennium Pharmaceuticals, Inc.. It is currently in Phase 1 development. Also known as: bortezomib, rifampicin.
At a glance
| Generic name | bortezomib, rifampicin |
|---|---|
| Also known as | bortezomib, rifampicin |
| Sponsor | Millennium Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bortezomib, rifampicin CI brief — competitive landscape report
- bortezomib, rifampicin updates RSS · CI watch RSS
- Millennium Pharmaceuticals, Inc. portfolio CI
Frequently asked questions about bortezomib, rifampicin
What is bortezomib, rifampicin?
bortezomib, rifampicin is a Small molecule drug developed by Millennium Pharmaceuticals, Inc..
Who makes bortezomib, rifampicin?
bortezomib, rifampicin is developed by Millennium Pharmaceuticals, Inc. (see full Millennium Pharmaceuticals, Inc. pipeline at /company/millennium-pharmaceuticals-inc).
Is bortezomib, rifampicin also known as anything else?
bortezomib, rifampicin is also known as bortezomib, rifampicin.
What development phase is bortezomib, rifampicin in?
bortezomib, rifampicin is in Phase 1.
Related
- Manufacturer: Millennium Pharmaceuticals, Inc. — full pipeline
- Also known as: bortezomib, rifampicin
- Compare: bortezomib, rifampicin vs similar drugs
- Pricing: bortezomib, rifampicin cost, discount & access